Pfizer-BioNTech Begin Trials For An Omicron-Specific Vaccine
The trial will involve 1,420 people aged 18-55 (File)Washington: Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19…